|Redpoint Bio Corporation|
Albert Einstein Healthcare Network
5501 Old York Road
United States - Map
Redpoint Bio Corporation, a development stage biotechnology company, focuses on the development of healthier foods and new approaches for the treatment of diabetes and obesity by understanding the biology of taste and its relationship to metabolism, satiety, and diabetes. It enters into a license and commercialization agreement with International Flavors and Fragrances Inc. for the development, manufacture, use, and commercialization of RP44, which is a component of the stevia plant that works as a sweetness enhancer amplifying the existing sugary sweetness in a food or beverage. The company is based in Philadelphia, Pennsylvania.
|Mr. Scott M. Horvitz ,
Interim Chief Exec. Officer, Interim Pres, Chief Financial Officer, Principal Accounting Officer, Treasurer and Sec.
|Dr. Robert F. Margolskee M.D., Ph.D.,
Founder and Chairman of the Scientific Advisory Board
|Mr. Richard C. Lufkin ,
|Dr. R. Kyle Palmer Ph.D.,
Sr. Director of Discovery Research
|Amounts are as of Dec 31, 2011 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in USD.|